Phylogenetic internal control for HIV-1 genotypic antiretroviral testing

E. Boeri, F. Canducci, M. A. Grasso, S. Presi, P. Carrera, S. Racca, M. Clementi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Genotypic testing includes several steps (RNA purification, RT-PCR amplification, DNA sequencing, sequence editing and analysis) that should be individually controlled. In our laboratory, we have added to this step-by-step internal control a final phylogenetic quality control: this is performed every time a sequence is obtained from a patient previously subjected to the same test. Each sequence with this characteristic is routinely compared with sequences from previous samples of the same patient by multiple alignment and a neighbor-joining tree by using Kimura two-parameter method is constructed. To validate the quality control procedure, we have aligned and calculated the mean similarity of the reverse transcriptase (first 984 nucleotides) and protease (whole gene) sequences from 30 patients whose virus was completely wild-type for both reverse transcriptase and protease. In the same tree, we have added the sequences obtained from 5 out of the 30 patients, tested at a second time point. The wild type sequences have shown a mean inter-sample divergence of 2.9%, and all the sequence pairs from individual patients clustered together in the tree constructed with the nucleotide sequences, while the tree constructed with the inferred aminoacid sequences did not always permit to cluster the sequences from the same patients. This indicates that: 1) the phylogenetic analysis of nucleic acid sequences can be useful to rule out sample mix-up; 2) the belonging of a sequence to each individual patient can efficiently be assessed also in the cases of extreme divergence in terms of drug resistance mutations.

Original languageEnglish
Pages (from-to)105-109
Number of pages5
JournalNew Microbiologica
Volume27
Issue number2 SUPPL. 1
Publication statusPublished - 2004

Fingerprint

HIV-1
RNA-Directed DNA Polymerase
Quality Control
Peptide Hydrolases
DNA Sequence Analysis
Drug Resistance
Nucleic Acids
Sequence Analysis
Nucleotides
RNA
Viruses
Polymerase Chain Reaction
Mutation
Genes

Keywords

  • Diagnostic sequencing
  • Internal control
  • Phylogenetic tree
  • Protease
  • Reverse transcriptase

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Boeri, E., Canducci, F., Grasso, M. A., Presi, S., Carrera, P., Racca, S., & Clementi, M. (2004). Phylogenetic internal control for HIV-1 genotypic antiretroviral testing. New Microbiologica, 27(2 SUPPL. 1), 105-109.

Phylogenetic internal control for HIV-1 genotypic antiretroviral testing. / Boeri, E.; Canducci, F.; Grasso, M. A.; Presi, S.; Carrera, P.; Racca, S.; Clementi, M.

In: New Microbiologica, Vol. 27, No. 2 SUPPL. 1, 2004, p. 105-109.

Research output: Contribution to journalArticle

Boeri, E, Canducci, F, Grasso, MA, Presi, S, Carrera, P, Racca, S & Clementi, M 2004, 'Phylogenetic internal control for HIV-1 genotypic antiretroviral testing', New Microbiologica, vol. 27, no. 2 SUPPL. 1, pp. 105-109.
Boeri E, Canducci F, Grasso MA, Presi S, Carrera P, Racca S et al. Phylogenetic internal control for HIV-1 genotypic antiretroviral testing. New Microbiologica. 2004;27(2 SUPPL. 1):105-109.
Boeri, E. ; Canducci, F. ; Grasso, M. A. ; Presi, S. ; Carrera, P. ; Racca, S. ; Clementi, M. / Phylogenetic internal control for HIV-1 genotypic antiretroviral testing. In: New Microbiologica. 2004 ; Vol. 27, No. 2 SUPPL. 1. pp. 105-109.
@article{ed16182c29aa4773978ba8bd30feb33d,
title = "Phylogenetic internal control for HIV-1 genotypic antiretroviral testing",
abstract = "Genotypic testing includes several steps (RNA purification, RT-PCR amplification, DNA sequencing, sequence editing and analysis) that should be individually controlled. In our laboratory, we have added to this step-by-step internal control a final phylogenetic quality control: this is performed every time a sequence is obtained from a patient previously subjected to the same test. Each sequence with this characteristic is routinely compared with sequences from previous samples of the same patient by multiple alignment and a neighbor-joining tree by using Kimura two-parameter method is constructed. To validate the quality control procedure, we have aligned and calculated the mean similarity of the reverse transcriptase (first 984 nucleotides) and protease (whole gene) sequences from 30 patients whose virus was completely wild-type for both reverse transcriptase and protease. In the same tree, we have added the sequences obtained from 5 out of the 30 patients, tested at a second time point. The wild type sequences have shown a mean inter-sample divergence of 2.9{\%}, and all the sequence pairs from individual patients clustered together in the tree constructed with the nucleotide sequences, while the tree constructed with the inferred aminoacid sequences did not always permit to cluster the sequences from the same patients. This indicates that: 1) the phylogenetic analysis of nucleic acid sequences can be useful to rule out sample mix-up; 2) the belonging of a sequence to each individual patient can efficiently be assessed also in the cases of extreme divergence in terms of drug resistance mutations.",
keywords = "Diagnostic sequencing, Internal control, Phylogenetic tree, Protease, Reverse transcriptase",
author = "E. Boeri and F. Canducci and Grasso, {M. A.} and S. Presi and P. Carrera and S. Racca and M. Clementi",
year = "2004",
language = "English",
volume = "27",
pages = "105--109",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Phylogenetic internal control for HIV-1 genotypic antiretroviral testing

AU - Boeri, E.

AU - Canducci, F.

AU - Grasso, M. A.

AU - Presi, S.

AU - Carrera, P.

AU - Racca, S.

AU - Clementi, M.

PY - 2004

Y1 - 2004

N2 - Genotypic testing includes several steps (RNA purification, RT-PCR amplification, DNA sequencing, sequence editing and analysis) that should be individually controlled. In our laboratory, we have added to this step-by-step internal control a final phylogenetic quality control: this is performed every time a sequence is obtained from a patient previously subjected to the same test. Each sequence with this characteristic is routinely compared with sequences from previous samples of the same patient by multiple alignment and a neighbor-joining tree by using Kimura two-parameter method is constructed. To validate the quality control procedure, we have aligned and calculated the mean similarity of the reverse transcriptase (first 984 nucleotides) and protease (whole gene) sequences from 30 patients whose virus was completely wild-type for both reverse transcriptase and protease. In the same tree, we have added the sequences obtained from 5 out of the 30 patients, tested at a second time point. The wild type sequences have shown a mean inter-sample divergence of 2.9%, and all the sequence pairs from individual patients clustered together in the tree constructed with the nucleotide sequences, while the tree constructed with the inferred aminoacid sequences did not always permit to cluster the sequences from the same patients. This indicates that: 1) the phylogenetic analysis of nucleic acid sequences can be useful to rule out sample mix-up; 2) the belonging of a sequence to each individual patient can efficiently be assessed also in the cases of extreme divergence in terms of drug resistance mutations.

AB - Genotypic testing includes several steps (RNA purification, RT-PCR amplification, DNA sequencing, sequence editing and analysis) that should be individually controlled. In our laboratory, we have added to this step-by-step internal control a final phylogenetic quality control: this is performed every time a sequence is obtained from a patient previously subjected to the same test. Each sequence with this characteristic is routinely compared with sequences from previous samples of the same patient by multiple alignment and a neighbor-joining tree by using Kimura two-parameter method is constructed. To validate the quality control procedure, we have aligned and calculated the mean similarity of the reverse transcriptase (first 984 nucleotides) and protease (whole gene) sequences from 30 patients whose virus was completely wild-type for both reverse transcriptase and protease. In the same tree, we have added the sequences obtained from 5 out of the 30 patients, tested at a second time point. The wild type sequences have shown a mean inter-sample divergence of 2.9%, and all the sequence pairs from individual patients clustered together in the tree constructed with the nucleotide sequences, while the tree constructed with the inferred aminoacid sequences did not always permit to cluster the sequences from the same patients. This indicates that: 1) the phylogenetic analysis of nucleic acid sequences can be useful to rule out sample mix-up; 2) the belonging of a sequence to each individual patient can efficiently be assessed also in the cases of extreme divergence in terms of drug resistance mutations.

KW - Diagnostic sequencing

KW - Internal control

KW - Phylogenetic tree

KW - Protease

KW - Reverse transcriptase

UR - http://www.scopus.com/inward/record.url?scp=11844257589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11844257589&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 105

EP - 109

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 2 SUPPL. 1

ER -